Literature DB >> 10839324

Association of sympathomimetic drugs with malformations.

E Gilbert-Barness1, R M Drut.   

Abstract

We observed 2 cases of severe limb defects in infants following the use of sympathomimetic drugs during pregnancy. The mother of I had taken large doses of Primatene (ephedrine, theophylline, phenobarbital) as tablets and mist throughout pregnancy. The infant was born with oligoectrosyndactyly. In the other infant, maternal ingestion of sympathomimetic drugs including Triaminic (pseudoephedrine, phenylephrine, phenylpropanolamine) was associated with distal limb defects. Experimental studies in pregnant rabbits using Primatene in both low and high dosage resulted in limb reduction defects and other malformations in a significant number of the offspring compared with controls. Limb defects in the offspring of chicks following exposure to sympathomimetic drugs had previously been observed. We suggest that these agents may be teratogenic in the human and should be used with great caution or avoided during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839324

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  4 in total

1.  Use of decongestants during pregnancy and the risk of birth defects.

Authors:  Wai-Ping Yau; Allen A Mitchell; Kueiyu Joshua Lin; Martha M Werler; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2013-07-03       Impact factor: 4.897

Review 2.  Treating common ear problems in pregnancy: what is safe?

Authors:  Petros V Vlastarakos; Thomas P Nikolopoulos; Leonidas Manolopoulos; Eleftherios Ferekidis; George Kreatsas
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-23       Impact factor: 2.503

3.  Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects.

Authors:  Martha M Werler; Jaclyn L F Bosco; Stuart K Shapira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-01

Review 4.  Treating common problems of the nose and throat in pregnancy: what is safe?

Authors:  Petros V Vlastarakos; Leonidas Manolopoulos; Eleftherios Ferekidis; Aris Antsaklis; Thomas P Nikolopoulos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-12       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.